Inscobee Inc. has filed 11 insider transactions across 1 company since May 2025.
Most recent transaction: a transaction of 71090 shares of Apimeds Pharmaceuticals US, Inc. ($APUS) on May 12, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Inscobee Inc. | TenPercentOwner | C | Common Stock, par value $0.01 per share | 71090 | $2.60 | 2,055,706.0000 | 7,903,850 | 3.58% | 0.90% |
| May 12, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Inscobee Inc. | TenPercentOwner | C | Common Stock, par value $0.01 per share | 44041 | $2.60 | 2,099,747.0000 | 7,903,850 | 2.14% | 0.56% |
| May 12, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Inscobee Inc. | TenPercentOwner | C | Convertible Promissory Note | 184833 | $0.00 | 0.0000 | 7,903,850 | 0.00% | 2.34% |
| May 12, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Inscobee Inc. | TenPercentOwner | C | Convertible Promissory Note | 114507 | $0.00 | 0.0000 | 7,903,850 | 0.00% | 1.45% |
| May 12, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Inscobee Inc. | TenPercentOwner | P | Common Stock, par value $0.01 per share | 500000 | $4.00 | 6,372,324.0000 | 7,903,850 | 8.51% | 6.33% |
| May 12, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Inscobee Inc. | TenPercentOwner | C | Common Stock, par value $0.01 per share | 182002 | $2.60 | 6,345,275.0000 | 7,903,850 | 2.95% | 2.30% |
| May 12, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Inscobee Inc. | TenPercentOwner | C | Common Stock, par value $0.01 per share | 71090 | $2.60 | 6,416,365.0000 | 7,903,850 | 1.12% | 0.90% |
| May 12, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Inscobee Inc. | TenPercentOwner | C | Common Stock, par value $0.01 per share | 44041 | $2.60 | 6,416,365.0000 | 7,903,850 | 0.69% | 0.56% |
| May 12, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Inscobee Inc. | TenPercentOwner | C | Convertible Promissory Note | 473205 | $0.00 | 0.0000 | 7,903,850 | 100.00% | 5.99% |
| May 12, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Inscobee Inc. | TenPercentOwner | C | Convertible Promissory Note | 184833 | $0.00 | 0.0000 | 7,903,850 | 100.00% | 2.34% |
| May 12, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Inscobee Inc. | TenPercentOwner | C | Convertible Promissory Note | 114507 | $0.00 | 0.0000 | 7,903,850 | 100.00% | 1.45% |